TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/24 16:04 | 12/9/24 | STOK | Stoke Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | MA | DO | CEO | S | -88 | 12.99 | 0 | -7 | -10 | 62 | D | ||||||||||||||
12/10/24 19:00 | 12/6/24 | STOK | Stoke Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | MA | DO | CEO | S | -79 | 12.78 | 0 | -6 | -8 | 69 | D | ||||||||||||||
5/22/24 16:17 | 5/20/24 | STOK | Stoke Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | MA | DO | CEO | S | -654 | 15.43 | 0 | -42 | -61 | 27 | D | ||||||||||||||
3/19/24 20:30 | 3/19/24 | STOK | Stoke Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | MA | DO | CEO | S.d | -68 | 6.10 | 0 | -11 | -14 | 69 | D | ||||||||||||||
8/8/22 16:01 | 8/5/22 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | CA | D | S.d | -571 | 50.00 | 0 | -11 | -48 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |